EE04415B1 - Antimükootilist toimet omava ühendi farmatseutiline peroraalne preparaat ja selle valmistamismeetod - Google Patents

Antimükootilist toimet omava ühendi farmatseutiline peroraalne preparaat ja selle valmistamismeetod

Info

Publication number
EE04415B1
EE04415B1 EEP200100041A EEP200100041A EE04415B1 EE 04415 B1 EE04415 B1 EE 04415B1 EE P200100041 A EEP200100041 A EE P200100041A EE P200100041 A EEP200100041 A EE P200100041A EE 04415 B1 EE04415 B1 EE 04415B1
Authority
EE
Estonia
Prior art keywords
compound
preparation
coat
antifungic
inert core
Prior art date
Application number
EEP200100041A
Other languages
English (en)
Estonian (et)
Inventor
Picornell Darder Carlos
Original Assignee
Liconsa, Liberacion Controlada De Sustancias Activas, S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8304581&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EE04415(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Liconsa, Liberacion Controlada De Sustancias Activas, S.A. filed Critical Liconsa, Liberacion Controlada De Sustancias Activas, S.A.
Publication of EE200100041A publication Critical patent/EE200100041A/xx
Publication of EE04415B1 publication Critical patent/EE04415B1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
EEP200100041A 1998-07-21 1999-07-20 Antimükootilist toimet omava ühendi farmatseutiline peroraalne preparaat ja selle valmistamismeetod EE04415B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES009801539A ES2157731B1 (es) 1998-07-21 1998-07-21 Preparacion farmaceutica oral de un compuesto de actividad antifungica y procedimiento para su preparacion.
PCT/ES1999/000230 WO2000004881A1 (es) 1998-07-21 1999-07-20 Preparacion farmaceutica oral de un compuesto de actividad antifungica y procedimiento para su preparacion

Publications (2)

Publication Number Publication Date
EE200100041A EE200100041A (et) 2002-06-17
EE04415B1 true EE04415B1 (et) 2005-02-15

Family

ID=8304581

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200100041A EE04415B1 (et) 1998-07-21 1999-07-20 Antimükootilist toimet omava ühendi farmatseutiline peroraalne preparaat ja selle valmistamismeetod

Country Status (31)

Country Link
US (1) US6737082B1 (cs)
EP (1) EP1103252B1 (cs)
JP (1) JP4190732B2 (cs)
KR (1) KR100572135B1 (cs)
AT (1) ATE234077T1 (cs)
AU (1) AU750730B2 (cs)
BG (1) BG65187B1 (cs)
BR (1) BR9912300A (cs)
CA (1) CA2337509C (cs)
CZ (1) CZ291938B6 (cs)
DE (1) DE69905905T2 (cs)
DK (1) DK1103252T3 (cs)
EE (1) EE04415B1 (cs)
ES (2) ES2157731B1 (cs)
HK (1) HK1037531A1 (cs)
HR (1) HRP20010128B1 (cs)
HU (1) HU228895B1 (cs)
IL (1) IL140910A (cs)
ME (1) MEP26708A (cs)
MX (1) MXPA01000681A (cs)
NO (1) NO320054B1 (cs)
NZ (1) NZ509886A (cs)
PL (1) PL194740B1 (cs)
PT (1) PT1103252E (cs)
RS (1) RS50063B (cs)
RU (1) RU2209628C2 (cs)
SK (1) SK283279B6 (cs)
TR (1) TR200100177T2 (cs)
UA (1) UA64009C2 (cs)
WO (1) WO2000004881A1 (cs)
ZA (1) ZA200101293B (cs)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0877563T3 (da) * 1996-01-31 2004-07-26 Univ South Alabama Levnedsmiddel- og vitaminpræparater, der indeholder den naturlige isomer af reducerede folater
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
EP1712222A3 (en) 1999-12-23 2012-06-20 Pfizer Products Inc. Pharmaceutical compositions providing enhanced drug concentrations
FR2842736B1 (fr) 2002-07-26 2005-07-22 Flamel Tech Sa Formulation pharmaceutique orale sous forme d'une pluralite de microcapsules permettant la liberation prolongee de principe(s) actif(s) peu soluble(s)
US20040115287A1 (en) * 2002-12-17 2004-06-17 Lipocine, Inc. Hydrophobic active agent compositions and methods
PT1438961E (pt) * 2003-01-14 2007-05-31 Cimex Pharma Ag Composição bioquivalente de itraconazol disperso num polímero hidrofílico.
EP1438960B2 (en) * 2003-01-14 2012-12-19 Acino Pharma AG Compostion of itraconazole dispersed in a hydrophilic polymer having enhanced bioavailability
FR2852607B1 (fr) * 2003-03-20 2006-07-14 Procede de fabrication de microspheres de sucre de petite taille, les microspheres susceptibles d'etre obtenues par ce procede et leurs applications
FR2857591B1 (fr) * 2003-07-17 2007-11-02 Ethypharm Sa Particules comprenant un principe actif sous forme de co-precipite
DK1648467T3 (en) * 2003-07-17 2018-06-25 Janssen Sciences Ireland Uc PROCEDURE FOR MANUFACTURING PARTICLES CONTAINING AN ANTIVIRUS AGENT
FR2883179B1 (fr) 2005-03-18 2009-04-17 Ethypharm Sa Comprime enrobe
EP2404602A1 (en) 2005-08-22 2012-01-11 The Johns Hopkins University Hedgehog pathway antagonists to treat cancer
CN101283984B (zh) * 2007-04-12 2010-05-26 永胜药品工业股份有限公司 高生物使用率的经杀真菌剂和聚合物涂覆的核心微粒状物
US11304960B2 (en) 2009-01-08 2022-04-19 Chandrashekar Giliyar Steroidal compositions
JP2013521249A (ja) * 2010-03-05 2013-06-10 ビーエーエスエフ ソシエタス・ヨーロピア 融解物で被覆された医薬形態
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
WO2016033549A2 (en) 2014-08-28 2016-03-03 Lipocine Inc. (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
WO2016033556A1 (en) 2014-08-28 2016-03-03 Lipocine Inc. BIOAVAILABLE SOLID STATE (17-β)-HYDROXY-4-ANDROSTEN-3-ONE ESTERS
MA40982A (fr) * 2014-11-19 2017-09-26 Biogen Ma Inc Formulation de bille pharmaceutique comprenant du fumarate de diméthyle
CA2987177A1 (en) * 2015-05-25 2016-12-01 Sun Pharmaceutical Industries Limited Once-daily oral pharmaceutical composition of isotretinoin
AU2017310506B2 (en) 2016-08-11 2019-11-21 Dmk Pharmaceuticals Corporation Drug compositions
WO2018098501A1 (en) 2016-11-28 2018-05-31 Lipocine Inc. Oral testosterone undecanoate therapy
EP3720844A4 (en) 2017-12-08 2021-08-11 Adamis Pharmaceuticals Corporation MEDICINAL COMPOSITIONS
CN112313289A (zh) * 2018-04-27 2021-02-02 凸版印刷株式会社 缓释性复合颗粒、缓释性复合颗粒的制造方法、干燥粉体、以及壁纸
WO2023118082A1 (en) * 2021-12-22 2023-06-29 Palau Pharma, S.L.U. Multiparticulate albaconazole composition

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4267179A (en) * 1978-06-23 1981-05-12 Janssen Pharmaceutica, N.V. Heterocyclic derivatives of (4-phenylpiperazin-1-yl-aryloxymethyl-1,3-dioxolan-2-yl)methyl-1H-imidazoles and 1H-1,2,4-triazoles
US4916134A (en) * 1987-03-25 1990-04-10 Janssen Pharmacuetica N.V. 4-[4-[4-[4-[[2-(2,4-difluorophenyl)-2-(1H-azolylmethyl)-1,3-dioxolan-4-yl]me]phenyl]-1-piperazinyl]phenyl]triazolones
IE61651B1 (en) * 1990-07-04 1994-11-16 Zambon Spa Programmed release oral solid pharmaceutical dosage form
PH30929A (en) * 1992-09-03 1997-12-23 Janssen Pharmaceutica Nv Beads having a core coated with an antifungal and a polymer.
US5567441A (en) * 1995-03-24 1996-10-22 Andrx Pharmaceuticals Inc. Diltiazem controlled release formulation
DE69726729T2 (de) * 1996-05-20 2004-12-02 Janssen Pharmaceutica N.V. Fungizide mittel mit verbesserter bioverfügbarkeit
ZA974428B (en) * 1996-05-24 1997-11-24 Schering Corp Antifungal composition with enhanced bioavailability.
TR199802718T2 (xx) * 1996-06-28 1999-03-22 Schering Corporation Bir triazol mantara kar�� bile�i�ini i�eren a��zdan al�nan bile�im.
DE19626924C2 (de) * 1996-07-04 1999-08-19 Epazon B V Gerät zur Bereitstellung eines Atemgases
EE03904B1 (et) * 1997-03-26 2002-12-16 Janssen Pharmaceutica N.V. Graanul, farmatseutiline doseerimisvorm, graanulite valmistamismeetod ja ravimiga kaetud graanulid

Also Published As

Publication number Publication date
UA64009C2 (en) 2004-02-16
DE69905905T2 (de) 2004-03-04
NZ509886A (en) 2002-09-27
MEP26708A (en) 2010-06-10
CZ2001175A3 (en) 2001-05-16
US6737082B1 (en) 2004-05-18
ES2194480T3 (es) 2003-11-16
SK862001A3 (en) 2001-08-06
RS50063B (sr) 2009-01-22
PL345625A1 (en) 2002-01-02
CA2337509A1 (en) 2000-02-03
RU2209628C2 (ru) 2003-08-10
ES2157731B1 (es) 2002-05-01
AU750730B2 (en) 2002-07-25
DK1103252T3 (da) 2003-07-14
IL140910A (en) 2004-03-28
WO2000004881A1 (es) 2000-02-03
KR100572135B1 (ko) 2006-04-19
HRP20010128A2 (en) 2002-12-31
BG105282A (en) 2001-11-30
NO20010289L (no) 2001-03-07
JP2002521323A (ja) 2002-07-16
NO320054B1 (no) 2005-10-17
CZ291938B6 (cs) 2003-06-18
TR200100177T2 (tr) 2001-07-23
PT1103252E (pt) 2003-07-31
JP4190732B2 (ja) 2008-12-03
EE200100041A (et) 2002-06-17
EP1103252B1 (en) 2003-03-12
CA2337509C (en) 2005-12-27
BR9912300A (pt) 2001-04-17
ZA200101293B (en) 2001-08-21
ATE234077T1 (de) 2003-03-15
YU3901A (sh) 2003-08-29
HRP20010128B1 (en) 2003-12-31
IL140910A0 (en) 2002-02-10
ES2157731A1 (es) 2001-08-16
HUP0103708A3 (en) 2002-07-29
AU4782199A (en) 2000-02-14
EP1103252A1 (en) 2001-05-30
SK283279B6 (sk) 2003-05-02
HK1037531A1 (en) 2002-02-15
DE69905905D1 (de) 2003-04-17
HUP0103708A2 (hu) 2002-02-28
BG65187B1 (bg) 2007-06-29
NO20010289D0 (no) 2001-01-17
PL194740B1 (pl) 2007-06-29
HU228895B1 (en) 2013-06-28
KR20010070990A (ko) 2001-07-28
MXPA01000681A (es) 2002-04-24

Similar Documents

Publication Publication Date Title
EE04415B1 (et) Antimükootilist toimet omava ühendi farmatseutiline peroraalne preparaat ja selle valmistamismeetod
DE69935677D1 (de) Antibiotische hydrophile beschichtung
DE69431807D1 (de) Teilchenförmige synthetische Träger sowie Verfahren zu deren Herstellung
PT90153A (pt) Processo para a preparacao de composicoes farmaceuticas de libertacao controlada
BR9915087A (pt) Formulação farmacêutica oral revestida entérica, uso de uma qualidade de hidroxipropil celulose (hpc), processo para a munufatura de uma formulação farmacêutica oral revestida entérica, uso de uma formulação farmacêutica, e, método para o tratamento de doenças gastrointestinais em mamìferos, incluindo o homem
DK76892A (da) Genstand med friktionsnedsaettende overfladebelaegning samt fremgangsmaade til fremstilling af en saadan belagt genstand
EP0351760A3 (en) Feed additive for ruminants
CA2348398A1 (en) Water-soluble coating agents bearing initiator groups and coating process
RU2001104894A (ru) Пероральная фармацевтическая композиция на основе соединения, имеющего антигрибковую активность, и способ ее получения
CY1108132T1 (el) Μεθοδος και εγκατασταση δια τη διαβροχη και επιστρωση χαρτιου
ATE97567T1 (de) Eine suspension hydratisierter spheroide einer hydrophilen lipidsubstanz enthaltendes waessriges kosmetisches bzw. dermopharmazeutisches mittel.
HK1063017A1 (en) Microgranules based on active principle and methodfor making same
EP0998944A3 (en) Enteric coated formulation of a benzimidazole derivative and method for preparation thereof
HUP0203310A2 (hu) Benzimidazolszármazékot tartalmazó stabil gyógyszerkészítmények és eljárás ezek előállítására
JPS60137017A (ja) レジスト塗布装置
ES8800838A1 (es) Metodo de fabricacion de un nuevo dispositivo distribuidor para la descarga a velocidad controlada de farmacos.
ITRM940715A0 (it) Nuovi 1,5 derivati di 7a-metilperidroinden-3a-oli, attivi sul sistema cardiovascolare, procedimenti per la loro preparazione e composizione farmaceutiche che li contengono

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20051231

KB4A Valid patent at the end of a year

Effective date: 20061231

KB4A Valid patent at the end of a year

Effective date: 20071231

HC1A Change of owner name
KB4A Valid patent at the end of a year

Effective date: 20081231

KB4A Valid patent at the end of a year

Effective date: 20101231

MM4A Lapsed by not paying the annual fees

Effective date: 20140720